Pre- and post-operative plasmapheresis results in a dramatic drop in DSA levels, which reduces the risk of hyper-acute rejections and early antibody-mediated rejections
of the lung: a consensus report of the International Society for Heart and Lung Transplantation.
C4d, a complement product of classical pathway (12) (triggered by anti-donor antibody) is used as a durable marker for predicting antibody-mediated rejection
Banff 2011 meeting report: new concepts in antibody-mediated rejection
," American Journal of Transplantation, vol.
The importance of technological advances in laboratory-based testing in assessing the risk of antibody-mediated rejection
in renal transplantation is highlighted.
Guidelines for the diagnosis of antibody-mediated rejection
in pancreas allografts-updated Banff grading schema.
As C4d-negative antibody-mediated rejection
(AMR) was not a recognized entity in 2013; she was only treated with intravenous pulses of methylprednisolone and the creatinine stabilized at 160 [micro]mol/L.
Several monoclonal antibodies (MABs) are being studied to help solve the problem of antibody-mediated rejection
Nasdaq: ALXN) today announced that researchers are scheduled to present clinical and laboratory research on the role of terminal complement inhibition therapy in kidney transplantation patients at high risk for antibody-mediated rejection
(AMR) at the American Transplant Congress, being held May 1 to 5, 2010, in San Diego.
If antibody-mediated rejection
persists, plasmapheresis continues until it is treated and adequate allograft function ensues (Padmanabhan et al.
Treatment with sCD83 alone was capable of controlling antibody-mediated rejection
and prolonging survival of cardiac allografts by twofold when compared to untreated controls.
(AMR) in kidney and heart allografts has been thoroughly investigated and has been shown to be an important cause of acute and chronic rejection.